Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03745937” into the
search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00030” into the search box, and click “Find a Study”.
Full study title: A Phase 2a Randomized, Blinded, Placebo-controlled Study to
Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MEDI0382 in
Overweight/Obese Subjects with Type 2 Diabetes Mellitus
National Clinical Trials number: NCT03745937
AstraZeneca Protocol Number: D5670C00030
MedImmune Limited, a wholly owned subsidiary of AstraZeneca, sponsored this
study and has its headquarters in Cambridge, United Kingdom.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO
12
Version 1.0 2020_05_11